S 574 · 118th Congress
Increasing Prescription Drug Competition Act
<p><b>Increasing Prescription Drug Competition Act</b></p> <p>This bill provides that certifications in generic drug applications of certain patents involved in Risk Evaluation and Mitigation Strategy (REMS) programs have no effect upon the drug's approval. (The Food and Drug Administration sometimes requires a REM…
- Sponsor
- Hassan, Margaret Wood (D-NH)
- Introduced
- 2023-03-01
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍